friedreich ataxia: concepts for consumer campaigns
Client: When I was at Boundless Life Sciences, I did creative work for REATA Pharmaceuticals' SKYCLARYS for Friedreich Ataxia (FA)
Background and Challenge: Similar to ALS, FA is a rare, progressive neuromuscular disorder that reduces the body's ability to move. The challenge was to make noise about how SKYCLARYS is the first FDA-approved treatment for FA; it acts to slow the progress of the disease, enabling patients (typically diagnosed in their teens or 20s), to get more out of life.
Solution: Worked with my art director partner to bring these creative concepts to life.
Note: The creative work product shown here is not owned by me. It is shared solely for the purpose of demonstrating my creativity while working for Boundless Life, LLC.
Background and Challenge: Similar to ALS, FA is a rare, progressive neuromuscular disorder that reduces the body's ability to move. The challenge was to make noise about how SKYCLARYS is the first FDA-approved treatment for FA; it acts to slow the progress of the disease, enabling patients (typically diagnosed in their teens or 20s), to get more out of life.
Solution: Worked with my art director partner to bring these creative concepts to life.
Note: The creative work product shown here is not owned by me. It is shared solely for the purpose of demonstrating my creativity while working for Boundless Life, LLC.
